Oncology Economist Impact: World Cancer Series – pharmaphorum in atte... Taking a brief look back to pharmaphorum’s coverage of Day One of The Economist’s 8th Annual
News EU approves AZ's Imfinzi plus chemo for advanced biliary tra... AstraZeneca’s (AZ) Imfinzi (durvalumab) has been approved in the
Oncology Economist Impact: World Cancer Series – pharmaphorum in atte... To conclude pharmaphorum’s look back at day one of The Economist’s 8th Annual World Cancer Series congress in Brussels, Belgium, in November – where the foci were “innovation, equity, and e
Cancer Targeting the ecosystem to make cancer extinct The ICR and The Royal Marsden have embarked on an ambitious research collaboration to disrupt the cancer cell ecosystem.
News FDA approves Adstiladrin as first gene therapy for NMIBC The US Food and Drug Administration (FDA) has
News Regeneron, CytomX announce bispecific therapeutics for cance... Regeneron Pharmaceuticals, Inc. and CytomX Therapeutics, Inc.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
